Acute Ischemic Stroke

Overview

Journal Curr Treat Options Neurol

Specialty Neurology

Date 2000 Nov 30

PMID 11096699

Authors

Chan

Albers

Affiliations

Soon will be listed here.

Abstract

Patients with acute ischemic stroke should be immediately transported to the nearest hospital for rapid evaluation and treatment. Intravenous t-PA within 3 hours of symptom onset is the recommended treatment for patients who meet the National Institute of Neurological Disorders and Stroke (NINDS) study eligibility criteria. Patients should be informed of the risk of symptomatic cerebral hemorrhage, and strict adherence to the NINDS study protocol is strongly recommended to optimize the risk-benefit ratio. Ischemic stroke patients who are not eligible for t-PA therapy should usually be started on aspirin. Intravenous heparin is not recommended as a standard treatment but may be considered for specific patient subgroups. Low-dose subcutaneous heparin is recommended for prophylaxis of deep vein thrombosis in immobilized patients. Management of stroke patients by a designated stroke team is recommended to facilitate prompt diagnosis and treatment and early initiation of rehabilitation therapy. We also recommend that physicians who manage patients with acute stroke maintain contact with local or regional stroke centers to facilitate referral of appropriate patients for intensive care or specialized diagnostic tests or therapies.

References

Albers G, Easton J, Sacco R, Teal P . Antithrombotic and thrombolytic therapy for ischemic stroke. Chest. 1998; 114(5 Suppl):683S-698S. DOI: 10.1378/chest.114.5_supplement.683s. View

. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group. Stroke. 1997; 28(11):2109-18. DOI: 10.1161/01.str.28.11.2109. View

Alexandrov A, Pullicino P, Meslin E, Norris J . Agreement on disease-specific criteria for do-not-resuscitate orders in acute stroke. Members of the Canadian and Western New York Stroke Consortiums. Stroke. 1996; 27(2):232-7. DOI: 10.1161/01.str.27.2.232. View

Rordorf G, Koroshetz W, Copen W, Cramer S, Schaefer P, Budzik Jr R . Regional ischemia and ischemic injury in patients with acute middle cerebral artery stroke as defined by early diffusion-weighted and perfusion-weighted MRI. Stroke. 1998; 29(5):939-43. DOI: 10.1161/01.str.29.5.939. View

Adams Jr H, Brott T, Furlan A, Gomez C, Grotta J, Helgason C . Guidelines for Thrombolytic Therapy for Acute Stroke: a Supplement to the Guidelines for the Management of Patients with Acute Ischemic Stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American.... Stroke. 1996; 27(9):1711-8. View

Schwab S, Steiner T, Aschoff A, Schwarz S, Steiner H, Jansen O . Early hemicraniectomy in patients with complete middle cerebral artery infarction. Stroke. 1998; 29(9):1888-93. DOI: 10.1161/01.str.29.9.1888. View

Wildermuth S, Knauth M, Brandt T, Winter R, Sartor K, Hacke W . Role of CT angiography in patient selection for thrombolytic therapy in acute hemispheric stroke. Stroke. 1998; 29(5):935-8. DOI: 10.1161/01.str.29.5.935. View

Ueda T, Hatakeyama T, Kumon Y, Sakaki S, Uraoka T . Evaluation of risk of hemorrhagic transformation in local intra-arterial thrombolysis in acute ischemic stroke by initial SPECT. Stroke. 1994; 25(2):298-303. DOI: 10.1161/01.str.25.2.298. View

Nakano S, Yokogami K, Ohta H, Yano T, Ohnishi T . Direct percutaneous transluminal angioplasty for acute middle cerebral artery occlusion. AJNR Am J Neuroradiol. 1998; 19(4):767-72. PMC: 8337415. View

10.

Einhaupl K, Villringer A, Meister W, Mehraein S, Garner C, Pellkofer M . Heparin treatment in sinus venous thrombosis. Lancet. 1991; 338(8767):597-600. DOI: 10.1016/0140-6736(91)90607-q. View

11.

Baird A, Benfield A, Schlaug G, Siewert B, Lovblad K, Edelman R . Enlargement of human cerebral ischemic lesion volumes measured by diffusion-weighted magnetic resonance imaging. Ann Neurol. 1997; 41(5):581-9. DOI: 10.1002/ana.410410506. View

12.

Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D . Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet. 1998; 352(9136):1245-51. DOI: 10.1016/s0140-6736(98)08020-9. View

13.

. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995; 333(24):1581-7. DOI: 10.1056/NEJM199512143332401. View

14.

Ueda T, Sakaki S, Nochide I, Kumon Y, Kohno K, Ohta S . Angioplasty after intra-arterial thrombolysis for acute occlusion of intracranial arteries. Stroke. 1998; 29(12):2568-74. DOI: 10.1161/01.str.29.12.2568. View

15.

. Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Multicentre Acute Stroke Trial--Italy (MAST-I) Group. Lancet. 1995; 346(8989):1509-14. View

16.

Alexandrov A, Bladin C, Norris J . Intracranial blood flow velocities in acute ischemic stroke. Stroke. 1994; 25(7):1378-83. DOI: 10.1161/01.str.25.7.1378. View

17.

Adams Jr H, Brott T, CROWELL R, Furlan A, Gomez C, Grotta J . Guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 1994; 25(9):1901-14. DOI: 10.1161/01.str.25.9.1901. View

18.

Norris J, Hachinski V . High dose steroid treatment in cerebral infarction. Br Med J (Clin Res Ed). 1986; 292(6512):21-3. PMC: 1338973. DOI: 10.1136/bmj.292.6512.21. View

19.

von Kummer R, Allen K, Holle R, Bozzao L, Bastianello S, Manelfe C . Acute stroke: usefulness of early CT findings before thrombolytic therapy. Radiology. 1997; 205(2):327-33. DOI: 10.1148/radiology.205.2.9356611. View

20.

Patel M, Edelman R, Warach S . Detection of hyperacute primary intraparenchymal hemorrhage by magnetic resonance imaging. Stroke. 1996; 27(12):2321-4. DOI: 10.1161/01.str.27.12.2321. View